Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

SynAct Pharma Major Shareholding Notification 2023

Nov 3, 2023

3114_iss_2023-11-03_1d23c9ad-0d16-4932-96c6-9ecd037cec77.pdf

Major Shareholding Notification

Open in viewer

Opens in your device viewer

Issuer SynAct Pharma AB

Holder

Thomas Jonassen

Instrument

Instrument Ordinary SE0008241491
Before the transaction
Shares 3,531,644
Voting rights 3,531,644
Transaction
Reason for major shareholding notification Invalidated
Date 01/11/2023
Limit for number of shares 10 %
Limit for number of votes 10 %
After the transaction
Quantity
Shares 2,489,644
Directly held voting rights 0
Indirectly held voting rights 2,489,644
Percentage
Directly held shares 6.99909 %
Directly held voting rights 0 %
Indirectly held voting rights 6.99909 %

Resulting distribution of total holdings

Percentage of voting
rights:
Number of underlying
shares:
Shares 6.99909 % 2,489,644
paragraph, line 2 Instruments - FITA Ch. 4, section 2,
first paragraph, line 3
Instruments - FITA Ch. 4, section 2, first
- Physically settled
- Cash settled
Total 6.99909 % 2,489,644
Chain of controlling companies
Voting rights % Voting rights Company
6.04792 6.04792 Bioinvest ApS
0.87005 0.87005 Goodwind Holding GmbH
0.08112 0.08112 TJ Biotech Holding ApS
Group total holdings
Voting rights 2,489,644
Percentage of voting rights 6.99909
Notes (other relevant informations according to law)
Makulerad per förfrågan från anmälare
Published

03/11/2023 16:47

[email protected] Tfn 08-408 980 37 Fax 08-24 39 25